Close Menu

MARCO ISLAND, Florida (GenomeWeb) – Geisinger Health and Johns Hopkins University have teamed up to study whether a liquid biopsy test that combines targeted circulating tumor DNA analysis with a number of protein markers can detect cancer early in healthy individuals.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.